|
SLC9A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.433600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.066000E-01 |
| Normal-vs-Stage2 |
7.764200E-01 |
| Normal-vs-Stage3 |
6.549400E-01 |
| Normal-vs-Stage4 |
4.249600E-01 |
| Stage1-vs-Stage2 |
5.882000E-01 |
| Stage1-vs-Stage3 |
7.564400E-01 |
| Stage1-vs-Stage4 |
2.503000E-01 |
| Stage2-vs-Stage3 |
4.806600E-01 |
| Stage2-vs-Stage4 |
6.810600E-01 |
| Stage3-vs-Stage4 |
1.971770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.806800E-01 |
| Normal-vs-AfricanAmerican |
1.416010E-01 |
| Normal-vs-Asian |
3.491200E-01 |
| Caucasian-vs-AfricanAmerican |
1.508030E-01 |
| Caucasian-vs-Asian |
3.075400E-01 |
| AfricanAmerican-vs-Asian |
3.911900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.563000E-01 |
| Normal-vs-Female |
6.899200E-01 |
| Male-vs-Female |
4.116400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.232800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.064400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.972200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.534800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.640000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.654000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.414400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.866800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.592400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.481600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.089200E-01 |
| Classical-VS-Follicular |
5.340200E-01 |
| Classical-VS-Other |
1.074010E-01 |
| Classical-VS-Normal |
7.772400E-01 |
| Tall-VS-Follicular |
7.726400E-01 |
| Tall-VS-Other |
9.272300E-02 |
| Tall-VS-Normal |
9.136000E-01 |
| Follicular-VS-Other |
2.293600E-01 |
| Follicular-VS-Normal |
8.307000E-01 |
| Other-VS-Normal |
8.458000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.226600E-01 |
| Normal-vs-N1 |
1.997960E-01 |
| N0-vs-N1 |
1.914000E-01 |
|
|
